58M with commercial insurance eligible for GLP-1 therapies #DYK 58 million people with commercial insurance are eligible for GLP-1 therapies, based on current FDA approvals
GLP-1 medication is not expected to provide the complete long-term maintenance framework once treatment changes
Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility
Interactions Medicines that interact with phentermine may either decrease its effect, affect how long it works, increase side effects, or have less of an effect when taken with phentermine
Think of the brain as a complex network, constantly adapting and changing based on new information and experiences
5 For example, recent preclinical and clinical observations highlight the role of gut-derived peptides such as GIP, GLP-2, and to a lesser extent, GLP-1 in the maintenance of overall skeletal health ( Figure 2 ), 6,7,8 opening new avenues for the understanding and potential treatment of bone disorders